These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 21394748)

  • 1. A test for the relationship between a time-varying marker and both recovery and progression with missing data.
    Schoenfeld DA; Rajicic N; Ficociello LH; Finkelstein DM
    Stat Med; 2011 Mar; 30(7):718-24. PubMed ID: 21394748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple imputation to estimate the association between eyes in disease progression with interval-censored data.
    Glynn RJ; Rosner B
    Stat Med; 2004 Nov; 23(21):3307-18. PubMed ID: 15493063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A semi-Markov model for multistate and interval-censored data with multiple terminal events. Application in renal transplantation.
    Foucher Y; Giral M; Soulillou JP; Daures JP
    Stat Med; 2007 Dec; 26(30):5381-93. PubMed ID: 17987670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing surrogacy from the joint modelling of multivariate longitudinal data and survival: application to clinical trial data on chronic lymphocytic leukaemia.
    Deslandes E; Chevret S
    Stat Med; 2007 Dec; 26(30):5411-21. PubMed ID: 18058850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting progression of renal insufficiency.
    Locatelli F; Manzoni C; Marcelli D
    Miner Electrolyte Metab; 1997; 23(3-6):301-5. PubMed ID: 9387138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying the treatment effect explained by markers in the presence of measurement error.
    Sarkar S; Qu Y
    Stat Med; 2007 Apr; 26(9):1955-63. PubMed ID: 16981176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intent-to-randomize corrections for missing data resulting from run-in selection bias in clinical trials for chronic conditions.
    Berger VW; Vali B
    J Biopharm Stat; 2011 Mar; 21(2):263-70. PubMed ID: 21391000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A semiparametric model for regression analysis of interval-censored failure time data.
    Finkelstein DM; Wolfe RA
    Biometrics; 1985 Dec; 41(4):933-45. PubMed ID: 3830259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar renal decline in diabetic and non-diabetic patients with comparable levels of albuminuria.
    Lorenzo V; Saracho R; Zamora J; Rufino M; Torres A
    Nephrol Dial Transplant; 2010 Mar; 25(3):835-41. PubMed ID: 19762600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of N-acetylcysteine on proteinuria and markers of tubular injury in non-diabetic patients with chronic kidney disease. A placebo-controlled, randomized, open, cross-over study.
    Renke M; Tylicki L; Rutkowski P; Larczyński W; Aleksandrowicz E; Lysiak-Szydłowska W; Rutkowski B
    Kidney Blood Press Res; 2008; 31(6):404-10. PubMed ID: 19092257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonparametric estimation in a Markov "illness-death" process from interval censored observations with missing intermediate transition status.
    Frydman H; Szarek M
    Biometrics; 2009 Mar; 65(1):143-51. PubMed ID: 18505421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptive covariate adjustment in clinical trials.
    Wang SJ; Hung HM
    J Biopharm Stat; 2005; 15(4):605-11. PubMed ID: 16022166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of dietary protein restriction on chronic progressive renal disease.
    Kasiske BL; Lakatua JD
    Miner Electrolyte Metab; 1997; 23(3-6):296-300. PubMed ID: 9387137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missing data methods for the assessment of surrogate outcomes and treatment mechanisms in clinical trial substudies.
    Galbraith S; Marschner IC; Simes J
    Stat Med; 2006 Feb; 25(3):415-31. PubMed ID: 16217855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A generalized log-rank test for interval-censored failure time data via multiple imputation.
    Huang J; Lee C; Yu Q
    Stat Med; 2008 Jul; 27(17):3217-26. PubMed ID: 18254128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generalized log-rank test for mixed interval-censored failure time data.
    Zhao Q; Sun J
    Stat Med; 2004 May; 23(10):1621-9. PubMed ID: 15122741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A global odds ratio regression model for bivariate ordered categorical data from ophthalmologic studies.
    Williamson J; Kim K
    Stat Med; 1996 Jul; 15(14):1507-18. PubMed ID: 8855477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M; Kawar B; El Nahas AM
    Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semiparametric estimation of time-dependent ROC curves for longitudinal marker data.
    Zheng Y; Heagerty PJ
    Biostatistics; 2004 Oct; 5(4):615-32. PubMed ID: 15475423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.